Opnext, Inc. (OPXT) halted for info
- Market Wrap: Chinese Stock Pressure Hits U.S. Markets; Durable Orders Outpace in June; Merger Monday
- Baidu.com (BIDU) Reports Q2 EPS of $1.81
- After-Hours Stock Movers 07/27: (GIG) (MSTR) (KN) Higher; (AMKR) (CKEC) (BIDU) Lower (more...)
- Wall Street drops as China stock slump stokes growth fears
- Teva Pharma (TEVA) to Acquire Allergan Genetics (AGN) in $40.5B Cash and Stock Deal
Opnext, Inc. (Nasdaq: OPXT) halted for info
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nymox Pharma (NYMX) Halted, News Pending
- Amkor Technology (AMKR) halted with news pending
- Esperion (ESPR) Resumes Following Halt, Pares Loss Following 20% Drop on Praluent Approval
Create E-mail Alert Related CategoriesTrading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!